Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
1999-06-21
2003-04-22
Sisson, B. L. (Department: 1655)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C435S004000, C435S006120, C435S069100, C435S069400, C435S183000, C436S501000, C530S399000
Reexamination Certificate
active
06551773
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to intracellular receptors, methods for the modulation thereof, and methods for the identification of novel ligands therefor. In a particular aspect, the present invention relates to methods for the identification of compounds which function as ligands (or ligand precursors) for intracellular receptors. In another aspect, the present invention relates to novel chimeric constructs and uses therefor.
BACKGROUND OF THE INVENTION
A central problem in eukaryotic molecular biology continues to be the elucidation of molecules and mechanisms that mediate specific gene regulation. As part of the scientific attack on this problem, a great deal of work has been done in efforts to identify ligands (i.e., exogenous inducers) which are capable of mediating specific gene regulation. Additional work has been done in efforts to identify other molecules involved in specific gene regulation.
Although much remains to be learned about the specifics of gene regulation, it is known that ligands modulate gene transcription by acting in concert with intracellular components, including intracellular receptors and discrete DNA sequences known as hormone response elements (HREs).
The identification of compounds which directly or indirectly interact with intracellular receptors, and thereby affect transcription of hormone-responsive genes, would be of significant value, e.g., for therapeutic applications.
Transcriptional silencing mediated by nuclear receptors plays an important role in development, cell differentiation, and is directly linked to the oncogenic activity of v-erbA. The mechanism underlying this effect is unknown but is one key to understanding the molecular basis of hormone action. Accordingly, the identification of components involved in transcriptional silencing would represent a great advance in current understanding of mechanisms that mediate specific gene regulation.
Other information helpful in the understanding and practice of the present invention can be found In commonly assigned U.S. Pat. Nos. 5,071,773 and 4,981,784; and U.S. patent application Ser. No. 326,240, filed Mar. 17, 1389 (now issued as U.S. Pat. No. 5,597,693, based on continuation in part application Ser. No. 494,618, filed Mar. 16, 1990); Ser. No. 370,407, filed Jun. 22, 1989 (now issued as U.S. Pat. No. 5,260,432) and Ser. No. 438,757, filed Nov. 16, 1989 (now issued as U.S. Pat. No. 5,091,518), all of which are hereby incorporated herein by reference in their entirety.
BRIEF DESCRIPTION OF THE INVENTION
In accordance with the present invention, we have discovered a novel receptor interacting factor, referred to herein as “SMRT”, i.e., a silencing mediator (co-repressor) for retinoic acid receptor (RAR) and thyroid hormone receptor (TR). SMRT is a novel protein whose association with RAR and TR both in solution and on DNA response elements is destabilized by ligand. The interaction of SMRT with mutant receptors correlates with the transcriptional silencing activities of receptors.
In vivo, SMRT functions as a potent co-repressor. A GAL4 DNA binding domain (DBD) fusion of SMRT behaves as a frank repressor of a GAL4-dependent reporter. Together, these data identify a novel class of cofactor which is believed to represent an important mediator of hormone action.
REFERENCES:
patent: 4981784 (1991-01-01), Evans et al.
patent: 5071773 (1991-12-01), Evans et al.
patent: 5091518 (1992-02-01), Sucov et al.
patent: 5260432 (1993-11-01), Takaku et al.
Ayer et al., “Mad-Max Transcriptional Repression is Mediated by Ternary Complex Formation with Mammalian Homologs of Yeast Repressor Sin3”Cell80:767-776 (1995).
Bahouth et al. “Immunological Approaches for Probing Receptor Structure and Function”TIPS Reviews12:338-343 (1991).
Baniahmad et al., “Modular Srurcture of a Chicken Lysozyme Silencer: Involvement of an Unusual Thyroid Hormone Receptor Binging Site”Cell61:505-514 (1990).
Baniahmad et al., “Kindred S Thyroid Hormone Receptor is an Active and Constitutive Silencer and a Repressor for Thyroid Hormone and Retinoic Acid Responses”Proc. Natl. Acad. Sci. USA89:10633-10637 (1992).
Baniahmad et al., “A Transferable Silencing Domain is Present in the Thyroid Hormone Receptor, in the v-erbA Oncogene Product and in the Retinoic Acid Receptor”EMBO J11(3):1015-1023 (1992).
Baniahmad et al., “Interaction of Human Thyroid Hormone Receptor &bgr; with Transcription Factor TFIIB May Mediate Target Gene Derepression and Activation by Thryoid Hormone”Proc. Natl. Acad. Sci. USA90:8832-8836 (1993).
Baniahmad et al., “The &tgr;4 Activation Domain of the Thyroid Hormone Receptor is Required for Release of a Putative Corepressor(s) Necessary for Transcriptional Silencing”Mol. Cell. Biol.15(1):76-86 (1995).
Barlow et al., “Thyroid Abnormalities and Hepatocellular Carcinoma in Mice Transgenic for v-erbA”EMBO J.13:4241-4250 (1994).
Berger et al., “Interaction of Glucocorticoid Analogues with the Human Glucocorticoid Receptor”J. Steroid Biochem. Molec. Biol.41(3-8):733-738 (1992).
Bourguet et al., “Crystal Structure of the Ligand-Binding Domain of the Human Nuclear Receptor RXR-&agr;”Nature375:377-382 (1995).
Brent et al., “Thyroid Hormone Aporeceptor Represses T3-Inducible Promoters and Blocks Activity of the Retinoic Acid Receptor”New Biol.1(3):329-336 (1989).
Bugge et al., “RXR&agr;, a Promiscuous Partner of Retinoic Acid and Thyroid Hormone Receptors”EMBO J.11(4):1409-1418 (1992).
Casanova et al., “Functional Evidence for Ligand-Dependent Dissociation of Thyroid Hormone and Retinoic Acid Receptors from a Inhibitory Cellular Factor”Mol. Cell. Biol.14(9):5756-5765 (1994).
Cavaillès et al., “Interaction of Proteins with Transcriptionally Active Estrogen Receptors”Proc. Natl. Acad. Sci. USA91:10009-10013 (1994).
Damm et al., “Protein Encoded by v-erbA Functions as a Thyroid-Hormone Receptor Antagonist”Nature339(6226):593-597 (1989).
Damm et al., “Functional Inhibition of Retinoic Acid Response by Dominant Negative Retinoic Acid Receptor Mutants”Proc. Natl. Acad. Sci. USA90:2989-2993 (1993).
Damm and Evans, “Identification of a Domain Required for Oncogenic Activity and Transcriptional Suppression by v-erbA and Thyroid-Hormone Receptor &agr;”Proc. Natl. Acad. Sci. USA90:10668-10672 (1993).
Durfee et al. “The Retinoblastoma Protein Associates with the Protein Phosphatase Type 1 Catalytic Subunit”Genes&Dev.7:555-569 (1993).
Fondell et al., “Unliganded Thyroid Hormone Receptor Inhibits Formation of a Functional Preinitiation Complex: Implications for Active Repression”Genes&Dev.7:1400-1410 (1993).
Gandrillon et al., “Expression of the v-erbA Oncogene in Chicken Embryo Fibroblasts Stimulates Their Proliferation In Vitro and Enhances Tumor Growth In Vivo”Cell49:687-697 (1987).
Halachmi et al., “Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription”Science264:1455-1458 (1994).
Hollenberg and Evans, “Multiple and Cooperative Trans-Activation Domains of the Human Glucocorticoid Receptor”Cell55:899-906 (1988).
Kliewer et al., “Retinoid X Receptor Interacts with Nuclear Receptors in Retinoic Acid, Thyroid Hormone and Vitamin D3Signalling”Nature355:446-449 (1992).
Le Douarin et al., “The N-terminal Part of TIF1, a Putative Mediator of the Ligand-Dependent Activation Function (AF-2) of Nuclear Receptors, is Fused to B-raf in the Oncogenic Protein T18”EMBO J.14(9):2020-2033 (1995).
Lee et al., “Interaction of the Thyroid-Hormone Receptor with a Conserved Transcriptional Mediator”Nature374:91-94 (1995).
Levine and Manley, “Transcriptional Repression of Eukaryotic Promoters”Cell59:405-408 (1989).
Mangelsdorf et al., “Nuclear Receptor that Identifies a Novel Retinoic Acid Response Pathway”Nature345(6272):224-229 (1990).
Mangelsdorf et al., “A Direct Repeat in the Cellular Retinol-Binding Protein Type II Gene Confers Differential Regulation by RXR and RAR”Cell66:555-561 (1991).
Muñoz et al. “Characterization of the Hormone-binding Domain of the Chicken c-erbA/Thyroid Hormone Receptor Protein”EMBO J.7:155-159 (1988).
Saitou et al., “Inhibition of Skin Development by Targeted Exp
Chen J. Don
Evans Ronald M.
LandOfFree
Transcriptional co-repressor that interacts with nuclear... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transcriptional co-repressor that interacts with nuclear..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transcriptional co-repressor that interacts with nuclear... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3102840